OHR Pharmaceutical Inc (NASDAQ:OHRP)

0.252
Delayed Data
As of Feb 23
 +0.0041 / +1.65%
Today’s Change
0.24
Today|||52-Week Range
2.18
-86.45%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.0M

Company Description

Ohr Pharmaceutical, Inc. is a pharmaceutical company, which focuses on the development of novel pharmaceuticals for the treatment of ocular diseases. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.

Contact Information

Ohr Pharmaceutical, Inc.
800 Third Avenue
New York New York 10022
P:(212) 682-8452
Investor Relations:

Employees

Shareholders

Mutual fund holders3.48%
Individual stakeholders12.60%
Other institutional12.05%

Top Executives

Jason Scott SlakterChief Executive Officer & Director
Samuel I. BackenrothCFO & Principal Accounting Officer
Glenn L. StollerChief Scientific Officer
Avner IngermanChief Clinical Officer
Peter K. KaiserSenior Vice President-Product Development